Table 2

Univariate analysis related to distant metastasis-free survival in 300 early stage patients with breast cancer

Patients, (n)Recurrence7-year DFS %*HR for Recurrence95% CI *HRp Value
Age (≤35/>35 years)9/2910/37100/840.000.03 to 4.140.4123
Pre/post Menopausal139/16124/1378/910.460.23 to 0.880.0194
Histological type
 Ductal2703085////0.4852
 Lobular20777
 Others100100
Tumour size
 T119017900.540.26 to 1.020.0577
 T21102076
Nodal status
 N019215900.410.19 to 0.750.0054
 N11082276
Grading
 Low342100 
 Intermediate1722186////0.0812
 High941474 
Oestrogen receptor
 Positive25030861.200.50 to 2.930.6561
 Negative50778 
Progesterone receptor
 Positive23528851.170.53 to 2.590.6785
 Negative65981 
HER2 status
 Negative2282289
 Positive7215760.560.23 to 1.060.0711
Triple negativity
 Yes303850.670.25 to 1.950.5056
 No2703485 
Ki-67
 ≤2010218901.010.52 to 1.970.9587
 > 201981982 
NLR
 Low (≤1.97)1349890.450.25 to 0.940.0337
 High (> 1.97)1662881 
  • p Values highlighted in bold are statistically significant.

  • *Median follow-up time.

  • NLR, neutrophil to lymphocyte ratio.